Loading clinical trials...
Loading clinical trials...
Identifying Predictors of Response in 12 Weeks of Treatment With Antipsychotics Using a Treatment Algorithm for Schizophrenia
The objective of this study is to evaluate predictors of response to antipsychotic medication in subjects with schizophrenia. The investigators will evaluate psychopathology,brain MRI, genetics and neuropsychological profile. Two groups of treatment will be compared: first generation antipsychotics vs. second generation antipsychotics. Participants will be randomized to one of the groups. Trial duration: 12 weeks.
Age
18 - 45 years
Sex
ALL
Healthy Volunteers
No
Instituto de Psiquiatria - Hospital das Clinicas FMUSP
São Paulo, São Paulo, Brazil
Start Date
April 1, 2009
Primary Completion Date
June 1, 2010
Completion Date
July 1, 2010
Last Updated
November 19, 2009
126
ESTIMATED participants
Antipsychotics
DRUG
Antipsychotics
DRUG
Lead Sponsor
University of Sao Paulo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions